Cargando…
Cisplatin in Liver Cancer Therapy
Hepatocellular carcinoma (HCC) is the most common primary liver tumor and is often diagnosed at an unresectable advanced stage. Systemic chemotherapy as well as transarterial chemoembolization (TACE) and hepatic arterial infusion chemotherapy (HAIC) are used to treat advanced HCC. TACE and HAIC have...
Autores principales: | Hamaya, Sae, Oura, Kyoko, Morishita, Asahiro, Masaki, Tsutomu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341575/ https://www.ncbi.nlm.nih.gov/pubmed/37446035 http://dx.doi.org/10.3390/ijms241310858 |
Ejemplares similares
-
The Roles of Epigenetic Regulation and the Tumor Microenvironment in the Mechanism of Resistance to Systemic Therapy in Hepatocellular Carcinoma
por: Oura, Kyoko, et al.
Publicado: (2023) -
Tumor Immune Microenvironment and Immunosuppressive Therapy in Hepatocellular Carcinoma: A Review
por: Oura, Kyoko, et al.
Publicado: (2021) -
Molecular and Functional Roles of MicroRNAs in the Progression of Hepatocellular Carcinoma—A Review
por: Oura, Kyoko, et al.
Publicado: (2020) -
Antitumor Effects and Mechanisms of Metabolic Syndrome Medications on Hepatocellular Carcinoma
por: Oura, Kyoko, et al.
Publicado: (2022) -
MicroRNA Interference in Hepatic Host-Pathogen Interactions
por: Morishita, Asahiro, et al.
Publicado: (2021)